+Ì(#uo2?kz«Å»óc>®

Material Safety Data Sheet
Polymer - Pink
Page 1 of 4
Section I - Product and Company Identification
Product Name:
Chemical Name:

Family: ACRYLIC POLYMER
Product Use: NAIL POLYMER
EMERGENCY Contatct: CHEM-TEL Inc. At 800-255-3924 or 813-248-0573
Section II - Hazardous Ingredients
Chemical Identity
CAS Numbers
INCI Name
Exposure
Carcinogen
N/E - None EstablishedN/R - Not ReviewedN/DA - No Data AvailableN/A - Not Applicable Section III - Hazards Identification
EMERGENCY OVERVIEW
• May cause allergic skin reaction.
• Dust may cause irritation of the nose, throat, and lungs.
• This product may contain particulate , not otherwise classified ( Nuisance Dust) Potential Health Effects, Signs and Symptoms of Exposure:
Primary Route of Entry
Eyes or skin (No absorption); inhalation of dust .
Higher concentration can irritate eyes. May cause eye irritation or damage.
Repeated or prolonged exposure may cause allergic skin rashes.
Higher concentration can irritate respiratory system.
Possible temporary discomfort due to inhalation of dust concentration above the permissible exposurelimit. Dust may cause irritation of the nose, throat, and lungs.
For Polymer: OSHA classifies this material as Particulates, Not Otherwise Classified. Eyes, skin andRespiratory tract may be irritated by gross overexposure to Particulates, Not Otherwise Classified, nomatter how they are generated. Avoid inhalation of dust. Keep dust out of eyes to prevent possibleirritation.
For decomposition product: Methyl Methacrylate Monomer; Liquid or high vapor concentration canirritate eyes, respiratory system and cause skin rashes. Prolonged exposure can lead to headaches,nausea, staggering gait, confusion, drowsiness and unconsciousness. Repeated and prolonged overexposure may cause permanent brain and nervous system damage, allergic skin rashes, eye corrosionand permanent injury, as well as changes in liver and kidney function or damage.
For Benzoyl Peroxide: repeated or prolonged contact may cause skin sensitization.
NOTE: Refer to Section 11, Toxicological Information for Details
Section IV - First Aid Measures
Flush with water for 15 minutes, including under eyelids. Get medical help if discomfort persists.
Wash with soap and water. Get medical help if discomfort persists.
Remove to fresh air. Get medical help if discomfort persists.
Rinse mouth out with water. Call doctor if amount was large.
Material Safety Data Sheet
Polymer - Pink
Page 2 of 4
Section V - Fire Fighting Measures
Flash Point
Flammable Limit
Auto-ignition Temperature
(°F/°C)
Water, carbon dioxide, dry chemical.
Avoid extinguishing methods that generate dust clouds. Water streams can disperse dust into air, producing a fire hazard and possible explosion hazard. Fire-fighters should wear self -contained breathing apparatus.
Polymer dust is combustible, explosive limits of the polymer particles suspended in air areapproximately those of coal dust.
Section VI - Accidental Release Measures
Sweep up to avoid slipping hazard. Keep airborne particulates at a minimum when cleaning Section VII - Handling and Storage
Observe precautions found on the label. Wash face and hands thoroughly with soap and waterafter handling and before eating, drinking or smoking.Avoid prolonged or repeated contactwith skin. Avoid contamination. Use only with adequate ventilation.
Store in cool, dry place away from heat, sparks, flame and direct sunlight. Close containerafter each use. Ground all metal conrainers when transferring. Use explosion-proof equipmentStore away from combustibles and incompatible materials.
Polymer dust is combustible, explosive limits of the polymer particles suspended in air areapproximately those of coal dust.
Section VIII - Exposure Controls / Personal Protective Equipment
Use good local exhaust at processing equipment, including buffers, sanders, grinders andpolishers . High temperature processing equipment should be well ventilated. Use explosion-proof equipment.Provide ventilation if necessary to control exposure levels below airborneexposure limits.
Dust collectors are recommended for handling powder in bulk.
Use safety glasses and have eye flushing equipment immediately available.
Minimize contamination by following good industrial practice. Wearing nitrile, neoprene, pvc,latex ot other impermeable gloves is recommended.
Avoid breathing dust and mist. Use dust mask.
Section IX - Physical and Chemical Properties
Appearance
Odor & Odor Threshold
Specific Gravity
Viscosity
% Volatile
Boiling Point/
Decomposition
Octanol/Water
Evaporation
Ignition
Solubility
Freezing Point
Temperature
Partitioning
Pressure:
Coefficient
Material Safety Data Sheet
Polymer - Pink
Page 3 of 4
Section X - Stability and Reactivity
Stability:
Incompatibility (Materials to Avoid):
Hazardous Decomposition Products:
Hazardous Polymerization:
Conditions to Avoid:
Heating above 240 deg C , 464 deg F
Section XI - Toxicological Information
Acute Oral Toxicity
Acute Dermal Toxicity
Acute Inhalation Toxicity
Irritation - skin
Irritation - Eye
Sensitization
Mutagenicity
Sub-chronic Toxicity
Section XII - Ecological Information
Ecotoxicological Information
Acute Toxicity
Acute Toxicity
Acute Toxicity
Bioconcentration
Toxicity to Sewage Bacteria
to Invertebrates
Chemical Fate Information
Biodegradability
Chemical Oxygen Demand
Section XIII - Disposable Concentrations
May be disposed of in a landfill or incinerated. Follow Federal, State and Local regulations for disposal.
Section XIV - Transport Information
DOT/ UN Shipping Name : Non- hazardous, not regulated.
Section XV - Regulatory Information
US Federal Regulations
This product contains no hazardous air pollutants (HAP) or ODS's, as defined by the U.
S. Clean Air Act.
This product does not contains no chemicals listed under the U.S. Clean Water ActPriority Pollutant List.
This product has not been cleared by the FDA for use in food packaging and/ orother applications as an indirect food additive.
This product does not contains hazardous chemical under the OSHA HazardCommunication Standard. Its hazards are: Immediate (acute ) health hazard; Reactive hazard; Fire hazard Material Safety Data Sheet
Polymer - Pink
Page 4 of 4
This product contains no chemicals considered to be hazardous waste underRCRA ( 40 CFR 261).
This product contains no chemicals regulated under Sec. 302 as extremelyhazardous substances.
This product contains no chemicals regulated under Sec. 304 as extremelyhazardous chemicals for emergency release notification ( "CERCLA " List).
This product contains hazardous substance under the OSHA HazardCommunication Standard and is regulated under Section 311 - 312 (40 CFR 370).
Its hazards are: None Immediate (acute) health hazard; None Reactive hazard; None Fire hazard None This product contains the following chemicals outlined in SARA Title III: Section 313:Benzoyl peroxide CAS #94-36-0.
This product contains chemicals listed on the TSCA inventory or otherwisecomplies with TSCA premanufacture notification requirements.
State Regulations
International Regulations
Benzoyl Peroxide CAS #94-36-0 is on the DSL list. WHMIS = C, D2B, B4 (on Canadian Transitional List)EINECS: European Inventory: • Hazard Symbol (XI E), R Values (R2, R36, R43), S Values (S3, S7, S14, Section XVI - Other Information
NFPA: Health = 1/Flammability = 1/Reactivity = 1HMIS: Health = 1 /Flammability/ = 1/Reactivity = 1 The information presented herein was obtained from sources considered to be reliable. However, this information is provided withoutany warranty, expressed or implied, regarding its correctness or suitability for consumers intended use and/or application. For this andother reasons, we assume no responsibility and expressly disclaim liability for loss, damage or expense arising out of any wayconnected with the handling, storage, use or disposal of the product. This MSDS was prepared expressly for this product. Use thematerials only as directed. If the product is used as a component of another product, the information contained within the MSDS maynot be applicable.

Source: http://www.planetnails.co.za/pinkpowder.pdf

Ngc_5460_1.doc

Complete Summary GUIDELINE TITLE Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. BIBLIOGRAPHIC SOURCE(S) Badesch DB, Abman SH, Ahearn GS, Barst RJ, McCrory DC, Simonneau G, McLaughlin VV. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004 Jul;126(1 Suppl):35S-62S. [191

Pii: s1470-0328(02)02325-x

BJOG: an International Journal of Obstetrics and GynaecologyFebruary 2003, Vol. 110, pp. 112 – 120Effect of timing and type of treatment on the risk of motherto child transmission of Toxoplasma gondiiEuropean Multicentre Study on Congenital Toxoplasmosis*Objective To determine the effects on mother to child transmission of the timing and type of prenataltreatment, taking into account gestat

Copyright © 2011-2018 Health Abstracts